Sonic Healthcare (OTCMKTS:SKHHY) Sets New 1-Year Low – Time to Sell?

Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY) reached a new 52-week low during trading on Thursday. The stock traded as low as $12.58 and last traded at $12.69, with a volume of 1,403 shares traded. The stock had previously closed at $12.75.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on SKHHY. The Goldman Sachs Group lowered shares of Sonic Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday. Zacks Research downgraded shares of Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Sell”.

Sonic Healthcare Price Performance

The business has a 50 day simple moving average of $14.10 and a 200 day simple moving average of $14.18.

Sonic Healthcare Company Profile

Sonic Healthcare Limited is an Australia-based healthcare company that provides medical diagnostic services. Its principal business is laboratory medicine, including clinical pathology, anatomical pathology, genetics, and other testing services used by physicians, hospitals, and other healthcare providers. The company also offers medical imaging and related diagnostic services in selected markets.

Founded in 1987 and headquartered in Sydney, Sonic Healthcare has expanded from its Australian pathology operations into an international healthcare group.